Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06013514
Other study ID # DM6 640 0101
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 2023
Est. completion date September 2035

Study information

Verified date August 2023
Source GC Aesthetics
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients can undergo breast implant surgery for multiple reasons; cosmetic and reconstructive being the primary indications. In order to confidently state safety and due to strict regulation on medical devices it is important to maintain a record of safety and performance with all medical implants. This study is designed to collect data on a new generation of smooth mammary implants to assess the long term performance and safety data on this type of gel-filled mammary breast implant. The two main complications of breast implants are capsular contracture and rupture; these complications can take years to develop. The study is designed to evaluate the occurrence of these two primary complication as well as other secondary complications over a period of 10 years. Patient follow up will be carried out pre-operatively and post operatively at 12 months and then 3, 5, 8 and 10 years thereafter. The study will be carried out over 10 years to adequately assess complications which may only occur over the lifetime of the device such as systemic complications


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 700
Est. completion date September 2035
Est. primary completion date September 2035
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Genetic female subjects aged =18 and =65 2. Subjects who underwent single or bilateral breast implantation with the study device for one of the following reasons:- i) Primary breast reconstruction following mastectomy (both for one-stage or two-stage surgeries, including patients with previous radiotherapy and who have ADMs of animal origin (bovine, porcine)). ii) Primary breast augmentation (cosmetic surgery) with or without mastopexy iii) Breast revision surgery with or without mastopexy c) Subjects who have received a Nagor PERLE implant. d) Subjects who have provided informed consent and can adhere to the requirements of follow up appointments as per the study protocol. Exclusion Criteria: 1. Subjects undergoing implant augmentation with a BMI > 30 and undergoing reconstruction with a BMI >32. 2. Subjects with autoimmune disease, lung fibrocystic disease, conditions that interfere with wound healing and blood clotting, a weakened immune system, reduced blood supply to the breast tissue or any other condition for which breast implants are contraindicated. 3. Subjects who have participated in a clinical study which involve chemical or drug study within 3 months prior to surgery, with the exception of subjects who are participating in breast cancer related clinical studies. 4. Subjects with insufficient tissue covering due to either radiation damage on the chest wall, tight thoracic skin grafts or radical resection of the pectoralis major muscle. 5. Subjects who have ADMs of synthetic origin. 6. Subjects who, in the Investigator's clinical opinion, have existing local or metastatic carcinoma of the breast that is unlikely to be fully excised at the time of insertion of the breast implant. 7. Subjects with known previous history of a sensitivity to silicone who, in the opinion of the Investigator, are unsuitable for surgery. 8. Subjects with an active infection who are unsuitable for surgery unless, in the opinion of the investigator, they are treated and cleared by the investigator. 9. Subjects with a history of abscesses anywhere in the body who, in the opinion of the Investigator, are unsuitable for surgery. 10. Subjects with a known history of compromised wound healing. 11. Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study. 12. Women who are pregnant and/or current breast feeders who do not stop breast feeding within 3 months of getting breast implants 13. Patients who have local recurrence or metastatic carcinoma at the time of insertion of breast implant

Study Design


Related Conditions & MeSH terms


Intervention

Device:
PERLE Sterile Smooth Opaque gel filled mammary implants
Sterile smooth opaque gel filled mammary implants will be implanted in adult women having breast surgery for either augmentation, reconstruction or revision surgery. Different ranges of implants will be used to suit patient needs

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
GC Aesthetics

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of capsular contracture (Baker grade III-IV) 10 years post-surgery
Primary Rate of implant rupture 10 years post-surgery
Secondary Rate of the secondary surgical procedures required for correction of complications 10 years post-surgery
Secondary Rate and frequency of local complications associated with the use of Nagor gel-filled mammary implants Capsular contracture of Baker Grade I-II
Haematoma
Rupture
Seroma
Severe and continuing pain
Post-operative infection
Explantation as a result of infection
Implant displacement/extrusion
Wrinkling/folds
Breast Implant Associate Anaplastic Large Cell Lymphoma
BII/Asia
Delayed or abnormal wound healing occurring within the first 3 months of surgery
Any other complications considered by the Investigator to be related to the device or surgical procedure
10 years post-surgery
Secondary Patient satisfaction BREAST- Q method 10 years post-surgery
Secondary rate and frequency of any adverse events 10 years post-surgery
See also
  Status Clinical Trial Phase
Recruiting NCT03757793 - Near-infrared Spectroscopy for Monitoring Tissue Oxygenation in Breast Reconstruction
Completed NCT05491473 - Negative Pressure in PAP Donor Sites
Completed NCT02169011 - Secondary Breast Reconstruction With a Flap of Skin From the Back N/A
Completed NCT01216319 - Evaluation of the Cook Biodesign Plastic Surgery Matrix N/A
Completed NCT01176786 - Reusable Versus Disposable Draping System in Breast Reconstruction Surgery N/A
Not yet recruiting NCT00973544 - Do Closed Suction Drains Affect the Complications Rate of Breast Reconstruction With Silicone Prosthesis? N/A
Active, not recruiting NCT00748722 - Pre-Operative Imaging of Abdominal Wall Perforators Using CT Angiography N/A
Completed NCT00753922 - Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses Phase 3
Completed NCT05897463 - Nipple Neurotization
Recruiting NCT05377723 - Abdominal Scar Improvement in Microsurgical Breast Reconstruction N/A
Completed NCT04350411 - Comparison of PEAK PlasmaBladeā„¢ to Conventional Diathermy in Abdominal Based Free Flap Breast Reconstruction N/A
Completed NCT06321549 - New Era of DIEP With Minimally Invasive Mastectomy
Withdrawn NCT03135392 - Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer N/A
Completed NCT01256502 - The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery N/A
Active, not recruiting NCT04715802 - Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
Active, not recruiting NCT04491591 - Implementing BREASTChoice Into Practice N/A
Recruiting NCT04661501 - BREAST ADM Trial for Alloplastic Breast Reconstruction N/A
Suspended NCT03625765 - Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye N/A
Withdrawn NCT00778947 - Single Centre Study to Compare Harmonic Scalpel to Conventional Diathermy in Free Tissue Transfer Breast Reconstruction N/A
Completed NCT00905645 - Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study N/A